RecallDex
Recalls
Categories
Companies
Stats
Recalls
Categories
Companies
Stats
Home
/
Companies
/
Aadi Bioscience
Aadi Bioscience
Pacific Palisades, CA, United States
1
Total Recalls
0
Class I Recalls
0
Ongoing Recalls
Recalls by Aadi Bioscience
FDA Drug
Class III
Terminated
Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.
October 13, 2022
Aadi Bioscience
2,333 vials units